STORM in the News

Nature: RNA epigenetics spurs investor interest, but uncertainties linger

John Hodgson speaks to Tony Kouzarides about why RNA epigenetics is an exciting area to invest in

https://www.nature.com/articles/nbt1218-1123

RNA Epigenetics in Human Disease

A STORM Therapeutics conference | 2021 Dates To be Confirmed

Find out more